Testing Anktiva for Long COVID Symptoms
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests a medicine called Anktiva to see if it can help people with Long COVID. It's for adults who had a confirmed COVID-19 infection and now have lasting symptoms like fatigue, brain fog, or trouble breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 69 years old.
- You had a confirmed COVID-19 infection (positive PCR or antigen test).
- You have at least two long COVID symptoms (like severe fatigue, 'brain fog', shortness of breath, or chest pain) that started or got worse after your COVID infection and have lasted more than 60 days.
- You do not have an autoimmune disease (such as rheumatoid arthritis, psoriasis, or inflammatory bowel disease).
- You are not currently hospitalized and are generally healthy otherwise.
- You are willing to use effective birth control if you or your partner could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for signs of Long COVID in the blood and gut to better understand the condition. If you have Long COVID or were exposed to the virus without developing it, you may be able to help.
This study tests if the drug Anktiva can help people with long COVID. To join, you must have had at least one confirmed COVID-19 infection and now have lasting symptoms that started or got worse after that infection.
This trial tests a natural compound to see if it can reduce ongoing inflammation and symptoms like fatigue, brain fog, or shortness of breath that linger after a COVID-19 infection. It's for people who still have symptoms at least 2 months after getting sick.
This trial tests whether the anti-inflammatory drug baricitinib can improve persistent long COVID symptoms like brain fog, fatigue, and shortness of breath. You may qualify if you had COVID-19 at least 6 months ago and still have bothersome symptoms that affect your daily life.
This study tests whether medicines that fight viruses (similar to those used for herpes or COVID) can reduce Long COVID symptoms like fatigue and brain fog. Researchers believe lingering viruses or viral reactivation may drive Long COVID, and this trial will see if antiviral drugs help.
This study tests whether a commonly used drug (repurposed) can help improve Long COVID symptoms like fatigue, breathing problems, or brain fog. It is for adults 18 to 65 who had COVID-19 in the past 4 years and still have symptoms after 3 months.
Hear when a new Long COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.